Dibya Sundar Panda1, Ranjan Kumar Giri2, Anil Kumar Nagarajappa3, Sakeenabi Basha4. 1. Department of Pharmaceutics, College of Pharmacy, Jouf University, Skaka, Kingdom of Saudi Arabia. 2. Department of Pharmacology, Institute of Pharmacy and Technology, Cuttack, India. 3. Oral Medicine & Radiology, Department of Oral & Maxillofacial Surgery & Diagnostic Sciences, College of Dentistry, Jouf University, Sakaka, Kingdom of Saudi Arabia. 4. Department of Community Dentistry, Faculty of Dentistry, Taif University, Taif, Saudi Arabia.
Abstract
Introduction: No medication or therapies were found to be effective in controlling the covid-19 pandemic. The fast-track development of covid-19 vaccine brought some hope among health practitioners globally. The major challenge seems to be safety, efficacy, and acceptance of the vaccine. A cross-sectional survey was conducted among the community of the state of Odisha, India, to find out the concerns of safety and acceptance for the vaccine. Methods: A self-administered multiple-choice questionnaire containing 23 items with three sections was prepared in Google form and deployed following snow ball sampling method. The participants recruited were above 18 years of age residing in Odisha. The participation in the survey was completely voluntary. The survey was conducted during February 2021.Results and discussion: In total, 359 members participated in the survey. Majority of the respondent strongly agree/agree that covid-19 vaccine is safe for adults and children. Significant variation among all the groups was found regarding acquisition of higher immunity following infection rather by vaccination, effectiveness in infection prevention, safety in children, provision of mandatory vaccination by government, and public health protection following government guidelines. Conclusion: The major barrier to the covid-19 vaccination was found to be safety and awareness. But there is well acceptance to covid-19 vaccine among the community of Odisha, India, and further efforts to create awareness concerning safety and vaccination will be instrumental in the eradication of this infection.
Introduction: No medication or therapies were found to be effective in controlling the covid-19 pandemic. The fast-track development of covid-19 vaccine brought some hope among health practitioners globally. The major challenge seems to be safety, efficacy, and acceptance of the vaccine. A cross-sectional survey was conducted among the community of the state of Odisha, India, to find out the concerns of safety and acceptance for the vaccine. Methods: A self-administered multiple-choice questionnaire containing 23 items with three sections was prepared in Google form and deployed following snow ball sampling method. The participants recruited were above 18 years of age residing in Odisha. The participation in the survey was completely voluntary. The survey was conducted during February 2021.Results and discussion: In total, 359 members participated in the survey. Majority of the respondent strongly agree/agree that covid-19 vaccine is safe for adults and children. Significant variation among all the groups was found regarding acquisition of higher immunity following infection rather by vaccination, effectiveness in infection prevention, safety in children, provision of mandatory vaccination by government, and public health protection following government guidelines. Conclusion: The major barrier to the covid-19 vaccination was found to be safety and awareness. But there is well acceptance to covid-19 vaccine among the community of Odisha, India, and further efforts to create awareness concerning safety and vaccination will be instrumental in the eradication of this infection.
Authors: Ludger Klimek; Natalija Novak; Eckard Hamelmann; Thomas Werfel; Martin Wagenmann; Christian Taube; Andrea Bauer; Hans Merk; Uta Rabe; Kirsten Jung; Wolfgang Schlenter; Johannes Ring; Adam Chaker; Wolfgang Wehrmann; Sven Becker; Norbert Mülleneisen; Katja Nemat; Wolfgang Czech; Holger Wrede; Randolf Brehler; Thomas Fuchs; Thilo Jakob; Tobias Ankermann; Sebastian M Schmidt; Michael Gerstlauer; Christian Vogelberg; Thomas Zuberbier; Karin Hartmann; Margitta Worm Journal: Allergo J Int Date: 2021-02-24
Authors: Mario García-Alanis; Marisa Morales-Cárdenas; Liz Nicole Toapanta-Yanchapaxi; Erwin Chiquete; Isaac Núñez; Santa Elizabeth Ceballos-Liceaga; Guillermo Carbajal-Sandoval; Carla Toledo-Salinas; David Alejandro Mendoza-Hernández; Selma Cecilia Scheffler-Mendoza; José Antonio Ortega-Martell; Daniel Armando Carrillo-García; Noé Hernández-Valdivia; Alonso Gutiérrez-Romero; Javier Andrés Galnares-Olalde; Fernando Daniel Flores-Silva; José Luis Díaz-Ortega; Gustavo Reyes-Terán; Hugo López-Gatell; Ricardo Cortes-Alcalá; José Rogelio Pérez-Padilla; Antonio Arauz; Miguel García-Grimshaw; Sergio Iván Valdés-Ferrer Journal: Vaccines (Basel) Date: 2022-08-11